Univercells Technologies, a leading provider of novel biomanufacturing technologies for flexible and scalable viral production, announces today a strategic partnership with RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and hMSC bioprocess systems. This ...
Read More »
ReNeuron announces a strategic update following a review of the latest data from the hRPC (human retinal progenitor cells) Phase 2a clinical trial for retinitis pigmentosa (RP) and an assessment of the commercial potential for its Exosome technology.
Read More »
The new cooperation is set under the heads of agreement and is aimed to offer highly characterized and standardized EV material for life science market to further accelerate the development of the EV applications in diagnostics and therapy...
Read More »
A spin-out of a Louisville-based health care company has closed on a rather large fundraising seed round. Nexosome Oncology raised $4 million in the round, which wrapped up at the end of 2021. The startup...
Read More »
Exopharm Limited has been granted US patent US 11202805 for its LEAP™ exosome purification technology. The latest research points to exosomes as a better and safer way to deliver modern medicines, including mRNA vaccines that currently use lipid...
Read More »
With the identified role of lipids in exosome biology and intercellular communication, Creative Biolabs highlights the importance of lipidomics in exosome research by providing complete lipidomic profiling services. Studies suggest that the exosomal composition in body fluids may contribute to ...
Read More »
Research to explore therapeutic potential of exosomes and other extracellular vesicles produced by neural stem cells derived from AgeX pluripotent...
Read More »
Innocan Pharma Corporation, is pleased to announce today that after the early substantial positive results of its CBD Loaded Exosome Platform (CLX), its Company’s wholly-owned subsidiary, InnoCan Pharma Ltd...
Read More »
The Cystic Fibrosis Foundation announced today that it has awarded more than $1.8 million to three companies for early-stage research into potential genetic therapies for cystic fibrosis as part of its Path to a Cure initiative, an ambitious research agenda to accelerate ...
Read More »
Codiak BioSciences, a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, today announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug Application (IND) for ...
Read More »
Exosome RNA Exosome RNA Research & Industry News
